SCHEMBL5240643

SCHEMBL5240643

FC(F)(F)Oc1ccc(CN2Cc3cc(Cl)cc(C(F)(F)F)c3C2)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
TSHR P16473 1/20 0.47
PRCP P42785 5/20 0.40
LMNA P02545 1/20 0.40
TNF P01375 1/20 0.40
NOD2 Q9HC29 1/20 0.40
NOD1 Q9Y239 1/20 0.40
HTR2C P28335 1/20 0.39
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
BACE1 P56817 2/20 0.39
GRIN2B Q13224 2/20 0.39
ACACB O00763 1/20 0.38
HCRTR1 O43613 2/20 0.38
HCRTR2 O43614 2/20 0.38
TEAD1 P28347 2/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5243101 0.88 ABCB1 (0.44) ALDH1A1LMNAHTR2C
SCHEMBL5243815 0.88 ALDH1A1 (0.52) ALDH1A1TSHRPRCPLMNATNF
SCHEMBL5239908 0.84 ALDH1A1 (0.52) ALDH1A1TSHRLMNATNFNOD2
SCHEMBL2022219 0.76 GRM2 (0.46) ALDH1A1TSHRHTR2CGRIN2BHCRTR1
SCHEMBL5240721 0.76 ALDH1A1 (0.50) ALDH1A1TSHRLMNATNFNOD2
SCHEMBL5243418 0.75 ALDH1A1 (0.50) ALDH1A1TSHRLMNATNFNOD2
SCHEMBL5241430 0.75 ALDH1A1 (0.52) ALDH1A1TSHRLMNATNFNOD2
SCHEMBL5242452 0.74 ALDH1A1 (0.51) ALDH1A1TSHRLMNATNFNOD2
SCHEMBL27685020 0.72 HCRTR1 (0.40) ALDH1A1TSHRHTR2CHCRTR1HCRTR2
SCHEMBL2056301 0.72 ALDH1A1 (0.58) ALDH1A1TSHRLMNATNFNOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778634-A1 ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS AstraZeneca AB (SE) 2007-05-02 EP disclosed
WO-2006020879-A1 ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS ASTRAZENECA AB (SE) 2006-02-23 WO disclosed